You bring up a very valid point Bernsta ,,, The level of due diligence carried out by the American Insto would have been far more in-depth than many of us could accomplish , They certainly didn't Bank on Acne as the sole avenue to financial success. Each facet of BOT would have been analysed , value proposition and failure and success rates in each of the BOT Trial programs , Eczema and Psoriasis plus the Anti Bacterial,,Anti Microbial Treatments.
Acne results were enough to more than satisfy regulators and now pushes forward into the Phase III arena.... 2020 looks Bright for BOT
2020 positivity, page-18
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $770.9M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.3¢ | 41.5¢ | $2.522M | 5.956M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 438567 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 219437 | 9 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |